Filings Intelligence
Company filings profile · CIK 0001488039

ATOSSA THERAPEUTICS, INC. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for ATOSSA THERAPEUTICS, INC. (ATOS): 3 filings in the last 90 days vs 18 in the prior 90 (filing-velocity cooling ↓ · 0.17×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.

Material 8-K events — ATOSSA THERAPEUTICS, INC.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 18, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Aug 7, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Jun 11, 2026Entry into a Material Agreement; Financial Statements and Exhibits↗
May 8, 2026Financial Statements and Exhibits↗
May 8, 2026Item 5.07↗
Apr 16, 2026Other Events↗
Mar 25, 2026Financial Statements and Exhibits↗
Feb 20, 2026Entry into a Material Agreement; Termination of a Material Agreement; Financial Statements and Exhibits↗
Feb 17, 2026Delisting / Listing-Rule Failure↗
Feb 11, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Jan 26, 2026Item 3.03; Amendments to Bylaws/Charter; Item 5.07; Financial Statements and Exhibits↗
Jan 9, 2026Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits↗
Jan 6, 2026Other Events; Financial Statements and Exhibits↗
Dec 4, 2025Other Events; Financial Statements and Exhibits↗
Nov 12, 2025Results of Operations (earnings); Financial Statements and Exhibits↗

Watch ATOSSA THERAPEUTICS, INC. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Watch this company →See a sample alert

Insider transactions (Form 4 / 3 / 5)

FiledForm
May 14, 20264↗
May 14, 20264↗
May 14, 20264↗
May 14, 20264↗
May 14, 20264↗
May 14, 20264↗
Mar 31, 20264↗
Mar 30, 20264↗
Jan 22, 20264↗
Oct 21, 20254↗
Oct 21, 20253↗
May 22, 20254↗
May 16, 20254↗
May 16, 20254↗
May 16, 20254↗
May 16, 20254↗
May 16, 20254↗
May 16, 20254↗
May 16, 20254↗
May 16, 20254↗

Recent filings

FiledFormDetail
Sep 18, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Aug 7, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Aug 7, 202610-Q 10-Q ↗
Jun 12, 2026424B5 424B5 ↗
Jun 11, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits ↗
May 14, 20264 4 ↗
May 14, 20264 4 ↗
May 14, 20264 4 ↗
May 14, 20264 4 ↗
May 14, 20264 4 ↗
May 14, 20264 4 ↗
May 8, 20268-K Financial Statements and Exhibits ↗
May 8, 202610-Q 10-Q ↗
May 8, 20268-K Item 5.07 ↗
Apr 16, 20268-K Other Events ↗
Mar 31, 20264 4 ↗
Mar 30, 20264 4 ↗
Mar 30, 2026ARS ARS ↗
Mar 30, 2026DEF 14A DEF 14A ↗
Mar 25, 202610-K 10-K ↗
Mar 25, 20268-K Financial Statements and Exhibits ↗
Mar 20, 2026PRE 14A PRE 14A ↗
Feb 20, 20268-K Entry into a Material Agreement; Termination of a Material Agreement; Financial Statements and Exhibits ↗
Feb 20, 2026424B5 424B5 ↗
Feb 20, 2026424B3 424B3 ↗
Feb 17, 20268-K Delisting / Listing-Rule Failure ↗
Feb 11, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Jan 30, 20264/A 4/A ↗
Jan 26, 20268-K Item 3.03; Amendments to Bylaws/Charter; Item 5.07; Financial Statements and Exhibits ↗
Jan 22, 20264 4 ↗
Jan 9, 20268-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits ↗
Jan 6, 20268-K Other Events; Financial Statements and Exhibits ↗
Dec 22, 2025DEF 14A DEF 14A ↗
Dec 12, 2025PRE 14A PRE 14A ↗
Dec 4, 20258-K Other Events; Financial Statements and Exhibits ↗
Nov 12, 202510-Q 10-Q ↗
Nov 12, 20258-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Oct 21, 20254 4 ↗
Oct 21, 20253 3 ↗
Oct 14, 20258-K Departure/Election of Directors or Officers; Regulation FD Disclosure ↗